Drug Profile
Losigamone
Alternative Names: AO 33Latest Information Update: 08 Sep 2005
Price :
$50
*
At a glance
- Originator Dr. Willmar Schwabe Group
- Class Antiepileptic drugs; Furans; Small molecules
- Mechanism of Action GABA A receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Partial epilepsies
Most Recent Events
- 06 Sep 2005 Discontinued - Phase-III for Partial seizures in European Union (PO)
- 06 Sep 2005 Discontinued - Phase-III for Partial seizures in USA (PO)
- 29 Jan 2003 Losigamone is available for licensing (www.schwabepharma.com)